, Tracking Stock Market Picks
Enter Symbol:
C.r. Bard, Inc. (BCR) [hlAlert]

up 88.46 %

C.r. Bard, Inc. (BCR) rated Buy by BofA/Merrill

Posted on: Monday,  Jan 14, 2013  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Buy C.r. Bard, Inc. (NYSE: BCR) on 01/14/2013, when the stock price was $104.26. Since
then, C.r. Bard, Inc. has gained 88.46% as of 01/20/2016's recent price of $196.49.
If you would have followed this BofA/Merrill's recommendation on BCR, you would have gained 88.46% of your investment in 1101 days.

C.R. Bard, Inc. is one of the worldwide leaders in developing, manufacturing, and supplying healthcare products that focus on Vascular, Urology, and Oncology Disease States. In addition, Bard offers a complete line of advanced Surgical Specialty products and services that address needs in hernia repair, performance irrigation, hemostasis, and other areas.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/14/2013 8:25 AM Buy
as of 12/13/2013
1 Week down  -2.79 %
1 Month down  -3.18 %
3 Months up  12.62 %
1 YTD up  28.14 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy